<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Annals of Clinical and Experimental Neurology</journal-id><journal-title-group><journal-title xml:lang="en">Annals of Clinical and Experimental Neurology</journal-title><trans-title-group xml:lang="ru"><trans-title>Анналы клинической и экспериментальной неврологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2075-5473</issn><issn publication-format="electronic">2409-2533</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">980</article-id><article-id pub-id-type="doi">10.17816/ACEN.980</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Reviews</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Обзоры</subject></subj-group><subj-group subj-group-type="article-type"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Rapid eye movement sleep behavior disorder: modern concept and Parkinson’s disease correlation</article-title><trans-title-group xml:lang="ru"><trans-title>Нарушения поведения в REM-фазе сна: современная концепция и взаимосвязь с болезнью Паркинсона</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1831-330X</contrib-id><contrib-id contrib-id-type="scopus">57204923376</contrib-id><contrib-id contrib-id-type="researcherid">GNW-6535-2022</contrib-id><contrib-id contrib-id-type="spin">8638-5837</contrib-id><name-alternatives><name xml:lang="en"><surname>Khasanova</surname><given-names>Diana M.</given-names></name><name xml:lang="ru"><surname>Хасанова</surname><given-names>Диана Магомедовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci. (Med.), neurologist, movement disorders specialist, Consultative and Diagnostic Center for Movement Disorders and Botulinum therapy of Tatarstan Republic</p></bio><bio xml:lang="ru"><p>к.м.н., невролог-паркинсонолог Консультативно-диагностического центра экстрапирамидной патологии и ботулинотерапии Республики Татарстан</p></bio><email>diana.khasanova1987@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8718-7266</contrib-id><contrib-id contrib-id-type="spin">9481-9152</contrib-id><name-alternatives><name xml:lang="en"><surname>Zalyalova</surname><given-names>Zuleykha A.</given-names></name><name xml:lang="ru"><surname>Залялова</surname><given-names>Зулейха Абдуллазяновна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>D. Sci. (Med.), Professor, Neurology and rehabi- litation department, Kazan State Medical University; Head, Consultative and Diagnostic Center for Movement Disorders and Botulinum therapy of Tatarstan Republic</p></bio><bio xml:lang="ru"><p>д.м.н., профессор каф. неврологии и реабилитации Казанского государственного медицинского университета; руководитель Консультативно-диагностического центра экстрапирамидной патологии и ботулинотерапии Республики Татарстан</p></bio><email>z.zalyalova@gmail.com</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0292-8182</contrib-id><name-alternatives><name xml:lang="en"><surname>Ilina</surname><given-names>Guzal R.</given-names></name><name xml:lang="ru"><surname>Ильина</surname><given-names>Гузаль Ринатовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci. (Med.), neurologist, Consultative and Diagnostic Center for Movement Disorders and Botulinum therapy of Tatarstan Republic</p></bio><bio xml:lang="ru"><p>к.м.н., врач-невролог Консультативно-диаг-ностического центра экстрапирамидной патологии и ботулинотерапии Республики Татарстан</p></bio><email>gusall_@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0005-7292-6069</contrib-id><name-alternatives><name xml:lang="en"><surname>Bagdanova</surname><given-names>Nailya I.</given-names></name><name xml:lang="ru"><surname>Багданова</surname><given-names>Наиля Искандеровна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci. (Med.), neurologist, Consultative and Diagnostic Center for Movement Disorders and Botulinum therapy of Tatarstan Republic</p></bio><bio xml:lang="ru"><p>к.м.н., врач-невролог Консультативно-диагностического центра экстрапирамидной патологии и ботулинотерапии Республики Татарстан</p></bio><email>nelia.bagdanova@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Consultative and Diagnostic Center for Movement Disorders and Botulinum Therapy of Tatarstan Republic</institution></aff><aff><institution xml:lang="ru">Консультативно-диагностический центр экстрапирамидной патологии и ботулинотерапии Республики Татарстан</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Kazan State Medical University</institution></aff><aff><institution xml:lang="ru">Казанский государственный медицинский университет</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2024-07-08" publication-format="electronic"><day>08</day><month>07</month><year>2024</year></pub-date><volume>18</volume><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>62</fpage><lpage>69</lpage><history><date date-type="received" iso-8601-date="2023-05-09"><day>09</day><month>05</month><year>2023</year></date><date date-type="accepted" iso-8601-date="2023-07-03"><day>03</day><month>07</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2024, Khasanova D.M., Zalyalova Z.A., Ilina G.R., Bagdanova N.I.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2024, Хасанова Д.М., Залялова З.А., Ильина Г.Р., Багданова Н.И.</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="en">Khasanova D.M., Zalyalova Z.A., Ilina G.R., Bagdanova N.I.</copyright-holder><copyright-holder xml:lang="ru">Хасанова Д.М., Залялова З.А., Ильина Г.Р., Багданова Н.И.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://annaly-nevrologii.com/pathID/article/view/980">https://annaly-nevrologii.com/pathID/article/view/980</self-uri><abstract xml:lang="en"><p>This review describes the association between rapid eye movement (REM) sleep behavior disorder (RBD) and synucleinopathies, primarily Parkinson's disease. This article reviews the diagnostic criteria, the epidemiology of RBDs, their pathogenesis, and their association with early non-motor symptoms. The data are presented to assess the risk of phenoconversion of RBDs to Parkinson's disease or other synucleinopathies such as Lewy body dementia and multiple system atrophy. A prodromal period of RBDs may precede synucleinopathies years or decades before potential manifestation of motor, cognitive, or autonomic disorders, and this may be important for initiating the neuroprotective therapy. Other causes of RBDs are also reviewed.</p></abstract><trans-abstract xml:lang="ru"><p>Обзор посвящён взаимосвязи нарушения поведения в фазе быстрого сна (фаза с быстрым движением глаз, Rapid eye movement, REM-фаза) и синуклеопатий, преимущественно болезни Паркинсона. Обсуждаются критерии постановки диагноза, эпидемиология нарушений поведения в REM-фазе сна, взаимосвязь с ранними немоторными симптомами заболевания, патогенетические причины развития нарушения поведения во сне. Представлены данные об оценке риска феноконверсии нарушений поведения в REM-фазе сна в болезнь Паркинсона или другие синуклеопатии: деменцию с тельцами Леви, мультисистемную атрофию. Продромальный период с нарушениями в REM-фазе сна может предвосхищать синуклеинопатии за годы или десятилетия до возможных явных двигательных, когнитивных или вегетативных нарушений, что может иметь важное значение для начала нейропротекторной терапии. Рассмотрены также другие причины появления нарушений в REM-фазе сна.</p></trans-abstract><kwd-group xml:lang="en"><kwd>Parkinson's disease</kwd><kwd>early stages</kwd><kwd>REM sleep behavior disorders</kwd><kwd>non-motor disorders</kwd><kwd>rapid eye movement sleep</kwd><kwd>alpha-synuclein</kwd><kwd>synucleinopathies</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>болезнь Паркинсона</kwd><kwd>начальные стадии</kwd><kwd>нарушения поведения в REM-фазе сна</kwd><kwd>немоторные нарушения</kwd><kwd>фаза сна с быстрым движением глаз</kwd><kwd>альфа-синуклеин</kwd><kwd>синуклеинопатии</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Darien I.L. American Academy of Sleep Medicine. International classification of sleep disorders — third edition (ICSD-3). Darien; 2014. 2313 p.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Boeve B.F., Silber M.H., Parisi J.E. et al. Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism. Neurology. 2003;61(1):40–45. DOI: 10.1212/01.wnl.0000073619.94467.b0</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Boeve B.F., Silber M.H., Ferman T.J. et al. Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy. Mov. Disord. 2001;16(4):622–630. DOI: 10.1002/mds.1120</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Postuma R.B., Gagnon J.F., Vendette M. et al. Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology. 2009;72(15):1296–1300. DOI: 10.1212/01.wnl.0000340980.19702.6e</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Boeve B.F., Silber M.H., Ferman T.J. et al. Clinicopathologic correlations I rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder. Sleep Med. 2013;14(8):754–762. DOI: 10.1016/j.sleep.2012.10.015</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Olson E.J., Boeve B.F., Silber M.H. Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases. Brain. 2000;123(Pt 2):331–339. DOI: 10.1093/brain/123.2.331</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>St Louis E.K., McCarter S.J., Boeve B.F. et al. Lesional REM sleep behavior disorder localizes to the dorsomedial pons. Neurology. 2014;83(20):1871–1873. DOI: 10.1212/WNL.0000000000000978</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Hancock K.L., St Louis E.K., McCarter S.J. et al. Quantitative analyses of REM sleep without atonia in children and adolescents with REM sleep beha- vior disorder. Minn. Med. 2014;97(5):43.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Boeve B.F. REM sleep behavior disorder: updated review of the core features, the REM sleep behavior disorder-neurodegenerative disease association, evolving concepts, controversies, and future directions. Ann. N. Y. Acad. Sci. 2010;1184:15–54. DOI: 10.1111/j.1749-6632.2009.05115.x</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Schenck C.H., Boeve B.F., Mahowald M.W. Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series. Sleep Med. 2013;14(8):744–748. DOI: 10.1016/j.sleep.2012.10.009</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>McCarter S.J., St Louis E.K., Sandnessd D.J. et al. Antidepressants increase REM sleep muscle tone in patients with and without REM sleep behavior disorder. Sleep. 2015;38(6):907–917. DOI: 10.5665/sleep.4738</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Wing Y.K., Li S.X., Mok V. et al. Prospective outcome of rapid eye movement sleep behaviour disorder: psychiatric disorders as a potential early marker of Parkinson's disease. Neurol. Neurosurg. Psychiatry. 2012;83(4):470–472. DOI: 10.1136/jnnp-2011-301232</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Frauscher B., Jennum P., Ju Y.E. et al. Comorbidity and medication in REM sleep behavior disorder: a multicenter case-control study. Neurology. 2014;82(12):1076–1079. DOI: 10.1212/WNL.0000000000000247</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Postuma R.B., Gagnon J.F., Tuineaig M. et al. Antidepressants and REM sleep behavior disorder: isolated side effect or neurodegenerative signal? Sleep. 2013;36(11):1579–1585. DOI: 10.5665/sleep.3102</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Postuma R.B., Gagnon J.F., Vendette M., Montplaisir J.Y. Markers of neurodegeneration in idiopathic rapid eye movement sleep behaviour disorder and Parkinson's disease. Brain. 2009;132(Pt 12):3298–3307. DOI: 10.1093/brain/awp244</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Teman P.T., Tippmann-Peikert M., Silber M.H. et al. Idiopathic rapid- eye-movement sleep disorder: associations with antidepressants, psychiatric diagnoses, and other factors, in relation to age of onset. Sleep Med. 2009;10(1):60–65. DOI: 10.1016/j.sleep.2007.11.019</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Hustad E., Aasly J.O. Clinical and imaging markers of prodromal Parkinson's disease. Front. Neurol. 2020;11:395. DOI: 10.3389/fneur.2020.00395</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Fernandez-Arcos A., Iranzo A., Serradell M. et al. The clinical phenotype of idiopathic rapid eye movement sleep behavior disorder at presentation: a study in 203 consecutive patients. Sleep. 2016;39(1):121–132. DOI: 10.5665/sleep.5332</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Howell M., Avidan A.Y., Foldvary-Schaefer N. et al. Management of REM sleep behavior disorder: an American Academy of Sleep Medicine clinical practice guideline. J. Clin. Sleep Med. 2023;19(4):759–768. DOI: 10.5664/jcsm.10424</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Ohayon M.M., Schenck C.H. Violent behavior during sleep: prevalence, comorbidity and consequences. Sleep Med. 2010;11(9):941–946. DOI: 10.1016/j.sleep.2010.02.016</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Frauscher B., Gschliesser V., Brandauer E. et al. REM sleep behavior disorder in 703 sleep-disorder patients: the importance of eliciting a comprehensive sleep history. Sleep Med. 2010;11(2):167–171. DOI: 10.1016/j.sleep.2009.03.011</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Kang S.H., Yoon I.Y., Lee S.D. et al. REM sleep behavior disorder in the Korean elderly population: prevalence and clinical characteristics. Sleep. 2013;36(8):1147–1152. DOI: 10.5665/sleep.2874.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Haba-Rubio J., Frauscher B., Marques-Vidal P. et al. Prevalence and determinants of rapid eye movement sleep behavior disorder in the general population. Sleep. 2018;41(2):zsx197. DOI: 10.1093/sleep/zsx197</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Boot B.P., Boeve B.F., Roberts R.O. et al. Probable rapid eye movement sleep behavior disorder increases risk for mild cognitive impairment and Parkinson disease: a population-based study. Ann. Neurol. 2012;71(1):49–56. DOI: 10.1002/ana.22655</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Mahlknecht P., Seppi K., Frauscher B. et al. Probable RBD and association with neurodegenerative disease markers: a populationbased study. Mov. Disord. 2015;30(10):1417–1421. DOI: 10.1002/mds.26350</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>St Louis E.K., Boeve A.R., Boeve B.F. REM sleep behavior disorder in Parkinson's disease and other synucleinopathies. Mov. Disord. 2017;32(5):645–658. DOI: 10.1002/mds.27018</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Wing Y.K., Lam S.P., Li S.X. et al. REM sleep behaviour disorder in Hong Kong Chinese: clinical outcome and gender comparison. J. Neurol. Neurosurg. Psychiatry. 2008;79(12):1415–1416. DOI: 10.1136/jnnp.2008.155374</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Iranzo A., Fernandez-Arcos A., Tolosa E. et al. Neurodegenerative disorder risk in idiopathic REM sleep behavior disorder: study in 174 patients. PLoS One. 2014;9(2):e89741. DOI: 10.1371/journal.pone.0089741</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Bonakis A., Howard R.S., Ebrahim I.O. et al. REM sleep behaviour disorder (RBD) and its associations in young patients. Sleep Med. 2009;10(6):641–645. DOI: 10.1016/j.sleep.2008.07.008</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Ju Y.E., Larson-Prior L., Duntley S. Changing demographics in REM sleep behavior disorder: possible effect of autoimmunity and antidepressants. Sleep Med. 2011;12(3):278–283. DOI: 10.1016/j.sleep.2010.07.022</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Bodkin C.L., Schenck C.H. Rapid eye movement sleep behavior disorder in women: relevance to general and specialty medical practice. J. Womens Health (Larchmt). 2009;18(12):1955–1963. DOI: 10.1089/jwh.2008.1348</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Boeve B.F., Silber M.H., Ferman T.J. REM sleep behavior disorder in Parkinson's disease and dementia with Lewy bodies. J. Geriatr. Psychiatry Neurol. 2004;17(3):146–157. DOI: 10.1177/0891988704267465</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Ferman T.J., Boeve B.F., Smith G.E. et al. Inclusion of RBD improves the diagnostic classification of dementia with Lewy bodies. Neurology. 2011;77(9):875–882. DOI: 10.1212/WNL.0b013e31822c9148</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Ferman T.J., Boeve B.F., Smith G.E. et al. Dementia with Lewy bodies may present as dementia and REM sleep behavior disorder without parkinsonism or hallucinations. J. Int. Neuropsychol. Soc. 2002;8(7):907–914. DOI: 10.1017/s1355617702870047</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>McCarter S.J., St Louis E.K., Boeve B.F. Mild cognitive impairment in rapid eye movement sleep behavior disorder: a predictor of dementia? Sleep Med. 2013;14(11):1041–1042. DOI: 10.1016/j.sleep.2013.08.780</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>McCarter S.J., St Louis E.K., Boeve B.F. REM sleep behavior disorder and REM sleep without atonia as an early manifestation of degenerative neurological disease. Curr. Neurol. Neurosci. Rep. 2012;12(2):182–192. DOI: 10.1007/s11910-012-0253-z</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Molano J., Boeve B., Ferman T. et al. Mild cognitive impairment associated with limbic and neocortical Lewy body disease: a clinicopathological study. Brain. 2010;133(Pt 2):540–556. DOI: 10.1093/brain/awp280</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Murray M.E., Ferman T.J., Boeve B.F. et al. MRI and pathology of REM sleep behavior disorder in dementia with Lewy bodies. Neurology. 2013;81(19):1681–1689. DOI: 10.1212/01.wnl.0000435299.57153.f0</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Chan P.C., Lee H.H., Hong C.T. et al. REM sleep behavior disorder (RBD) in dementia with lewy bodies (DLB). Behav. Neurol. 2018;9421098. DOI: 10.1155/2018/9421098</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Fereshtehnejad S.M., Montplaisir J.Y., Pelletier A. et al. Validation of the MDS research criteria for prodromal Parkinson's disease: longitudinal assessment in a REM sleep behavior disorder (RBD) cohort. Mov. Disord. 2017;32:865–873. DOI: 10.1002/mds.26989</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Berg D., Postuma R.B., Adler C.H. et al. MDS research criteria for prodromal Parkinson's disease. Mov. Disord. 2015;30(12):1600–1611. DOI: 10.1002/mds.26431</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Roguski A., Rayment D., Whone A.L. et al. A neurologist's guide to REM sleep behavior disorder. Front. Neurol. 2020;11:610. DOI: 10.3389/fneur.2020.00610</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Valencia G.S., Libourel P.A., Lazarus M. et al. Genetic inactivation of glutamate neurons in the rat sublaterodorsal tegmental nucleus recapitulates REM sleep behaviour disorder. Brain. 2017;140(2):414–428. DOI: 10.1093/brain/aww310</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Arrigoni E., Chen M.C., Fuller P.M. The anatomical, cellular and synaptic basis of motor atonia during rapid eye movement sleep. J. Physiol. 2016;594:5391–5414. DOI: 10.1113/JP271324</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Fraigne J.J., Torontali Z.A., Snow M.B., Peever J.H. REM sleep at its core — circuits, neurotransmitters, and pathophysiology. Front. Neurol. 2015;6:123. DOI: 10.3389/fneur.2015.00123</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Peever J., Luppi P.H., Montplaisir J. Breakdown in REM sleep circuitry underlies REM sleep behavior disorder. Trends Neurosci. 2014; 37:279–288. DOI: 10.1016/j.tins.2014.02.009</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Knudsen K., Fedorova T.D., Hansen A.K. et al. In vivo staging of pathology in REM sleep behaviour disorder: a multimodality imaging case-control study. Lancet Neurol. 2018;17:618–628. DOI: 10.1016/S1474-4422(18)30162-5</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Braak H., Ghebremedhin E., Rüb U. et al. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res. 2004;318(1):121–134. DOI: 10.1007/s00441-004-0956-9</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Miyamoto T., Miyamoto M., Inoeu Y. et al. Reduced cardiac 123I-MIBG scintigraphy in idiopathic REM sleep behavior disorder. Neurology. 2006;67(12):2236–2238. DOI: 10.1212/01.wnl.0000249313.25627.2e</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>Frauscher B., Normura T., Duerr S. et al. Investigation of autonomic function in idiopathic REM sleep behavior disorder. J. Neurol. 2012;259(6):1056–1061. DOI: 10.1007/s00415-011-6298-0</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>Postuma R.B., Gagnon J.F., Vendette M. et al. Olfaction and color vision identify impending neurodegeneration in rapid eye movement sleep beha- vior disorder. Ann. Neurol. 2011;69(5):811–818. DOI: 10.1002/ana.22282</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>Fantini M.L., Postuma R.B., Montplaisir J., Ferini-Strambi L. Olfactory deficit in idiopathic rapid eye movements sleep behavior disorder. Brain Res. Bull. 2006;70(4–6):386–390. DOI: 10.1016/j.brainresbull.2006.07.008</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>Beach T.G., Adler C.H., Lue L. et al. Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction. Acta Neuropathol. 2009;117(6):613–634. DOI: 10.1007/s00401-009-0538-8</mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation>Horsager J., Andersen K.B., Knudsen K. et al. Brain-first versus body-first Parkinson's disease: a multimodal imaging case-control study. Brain. 2020;143:3077–3088. DOI: 10.1093/brain/awaa238</mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation>Bohnen N.I., Postuma R.B. Body-first versus brain-first biological subtyping of Parkinson's disease. Brain. 2020;143:2871–2873. DOI: 10.1093/brain/awaa293</mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation>Horsager J., Knudsen K., Sommerauer M. Clinical and imaging evidence of brain-first and body-first Parkinson's disease. Neurobiol. Dis. 2022;164:105626. DOI: 10.1016/j.nbd.2022.105626</mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation>Bloch A., Probst A., Bissig H. et al. α-Synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects. Neuropathol. Appl. Neurobiol. 2006;32:284–295. DOI: 10.1111/j.1365-2990.2006.00727</mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation>Blesa J., Foffani G., Dehay B. et al. Motor and non-motor ircuit disturbances in early Parkinson disease: which happens first? Nat. Rev. Neurosci. 2022;23:115–128. DOI: 10.1038/s41583-021-00542-9</mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation>Warnecke T., Schäfer K.H., Claus I. et al. Gastrointestinal involvement in Parkinson's disease: pathophysiology, diagnosis, and management. NPJ Parkinsons Dis. 2022;8:1–13. DOI: 10.1038/s41531-022-00295-x</mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation>Adler C.H., Beach T.G. Neuropathological basis of nonmotor manifestations of Parkinson's disease. Mov. Disord. 2016;31(8):1114–1119. DOI: 10.1002/mds.26605</mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation>Залялова З.А., Хасанова Д.М. Эволюция предикторов ранней болезни Паркинсона. Бюллетень Национального общества по изучению болезни Паркинсона и расстройств движений. 2022;(2):72–75. DOI: 10.24412/2226-079X-2022-12438</mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation>Хасанова Д.М., Залялова З.А., Мунасипова С.Э. Нарушения сна у впервые выявленных пациентов с ранними стадиями болезни Паркинсона. Практическая медицина. 2020;18(5):117–123.</mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation>McCarter S.J., St. Louis E.K., Boeve B.F. Is rapid eye movement sleep behavior disorder in Parkinson disease a specific disease subtype? Sleep Med. 2013;14(10):931–933. DOI: 10.1016/j.sleep.2013.06.004</mixed-citation></ref><ref id="B64"><label>64.</label><mixed-citation>Nomura T., Xiong K.P., Li J. et al. Clinical significance of REM sleep beha- vior disorder in Parkinson's disease. Sleep Med. 2013;14(2):131–135. DOI: 10.1016/j.sleep.2012.10.011</mixed-citation></ref><ref id="B65"><label>65.</label><mixed-citation>Chahine L.M., Kauta S.R., Daley J.T. et al. Surface EMG activity during REM sleep in Parkinson's disease correlates with disease severity. Parkinsonism Relat. Disord. 2014;20(7):766–771. DOI: 10.1016/j.parkreldis.2014.04.011</mixed-citation></ref><ref id="B66"><label>66.</label><mixed-citation>Sixel-Doring F., Trautmann E., Mollenhauer B. et al. Associated factors for REM sleep behavior disorder in Parkinson disease. Neurology. 2011;77(11):1048–1054. DOI: 10.1212/WNL.0b013e31822e560e</mixed-citation></ref><ref id="B67"><label>67.</label><mixed-citation>Залялова З.А., Хасанова Д.М., Угрюмов М.В. Катехоламины плазмы крови у пациентов с ранними нелечеными стадиями болезни Паркинсона. Альманах клинической медицины. 2018;46(8):792–801. DOI: 10.18786/2072-0505-2018-46-8-792-801</mixed-citation></ref><ref id="B68"><label>68.</label><mixed-citation>Postuma R.B., Gagnon J.F., Vendette M. et al. REM sleep behaviour disorder in Parkinson's disease is associated with specific motor features. J. Neurol. Neurosurg. Psychiatry. 2008;79(10):1117–1121. DOI: 10.1136/jnnp.2008.149195</mixed-citation></ref><ref id="B69"><label>69.</label><mixed-citation>Lee J.E., Kim K.S., Shin H.W., Sohn Y.H. Factors related to clinically probable REM sleep behavior disorder in Parkinson disease. Parkinsonism Relat. Disord. 2010;16(2):105–108. DOI: 10.1016/j.parkreldis.2009.08.005</mixed-citation></ref><ref id="B70"><label>70.</label><mixed-citation>Sommerauer M., Valko P.O., Werth E. et al. Revisiting the impact of REM sleep behavior disorder on motor progression in Parkinson's disease. Parkinsonism Relat. Disord. 2014;20(4):460–462. DOI: 10.1016/j.parkreldis.2014.01.005</mixed-citation></ref><ref id="B71"><label>71.</label><mixed-citation>Postuma R.B., Bertrand J.A., Montplaisir J. et al. Rapid eye movement sleep behavior disorder and risk of dementia in Parkinson's disease: a prospective study. Mov. Disord. 2012;27(6):720–726. DOI: 10.1002/mds.24939</mixed-citation></ref><ref id="B72"><label>72.</label><mixed-citation>Vendette M., Gagnon J.F., Decary A. et al. REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia. Neurology. 2007;69(19):1843–1849. DOI: 10.1212/01.wnl.0000278114.14096.74</mixed-citation></ref><ref id="B73"><label>73.</label><mixed-citation>Plomhause L., Dujardin K., Duhamel A. et al. Rapid eye movement sleep behavior disorder in treatment-naive Parkinson disease patients. Sleep Med. 2013;14(10):1035–1037. DOI: 10.1016/j.sleep.2013.04.018</mixed-citation></ref><ref id="B74"><label>74.</label><mixed-citation>McKeith I.G., Dickson DW, Lowe J. et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65(12):1863–1872. DOI: 10.1212/01.wnl.0000187889.17253.b1</mixed-citation></ref><ref id="B75"><label>75.</label><mixed-citation>Pao W.C., Boev B.F., Ferman T.J. et al. Polysomnographic findings in dementia with Lewy bodies. Neurologist. 2013;19(1):1–6. DOI: 10.1097/NRL.0b013e31827c6bdd</mixed-citation></ref><ref id="B76"><label>76.</label><mixed-citation>Palma J.A., Fernandez-Cordon C., Coon E.A. et al. Prevalence of REM sleep behavior disorder in multiple system atrophy: a multicenter study and meta-analysis. Clin. Auton. Res. 2015;25(1):69–75. DOI: 10.1007/s10286-015-0279-9</mixed-citation></ref><ref id="B77"><label>77.</label><mixed-citation>Gagnon J.F., Petit D., Fantini M.L. et al. REM sleep behavior disorder and REM sleep without atonia in probable Alzheimer disease. Sleep. 2006;29(10):1321–1325. DOI: 10.1093/sleep/29.10.1321</mixed-citation></ref><ref id="B78"><label>78.</label><mixed-citation>Arnulf I., Merino-Andreu M., Bloch F. et al. REM sleep behavior disorder and REM sleep without atonia in patients with progressive supranuclear palsy. Sleep. 2005;28(3):349–354.</mixed-citation></ref><ref id="B79"><label>79.</label><mixed-citation>Boeve B.F., Lin S.C., Strongosky A. et al. Absence of rapid eye movement sleep behavior disorder in 11 members of the pallidopontonigral degeneration kindred. Arch. Neurol. 2006;63(2):268–272. DOI: 10.1001/archneur.63.2.268</mixed-citation></ref><ref id="B80"><label>80.</label><mixed-citation>De Cock V.C., Lannuzel A., Verhaeghe S. et al. REM sleep behavior disorder in patients with guadeloupean parkinsonism, a tauopathy. Sleep. 2007;30(8):1026–1032. DOI: 10.1093/sleep/30.8.1026</mixed-citation></ref><ref id="B81"><label>81.</label><mixed-citation>Sabater L., Gaig C., Gelpi E. et al. A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study. Lancet Neurol. 2014;13(6):575–586. DOI: 10.1016/S1474-4422(14)70051-1</mixed-citation></ref><ref id="B82"><label>82.</label><mixed-citation>Schenck C.H., Mahowald M.W. Motor dyscontrol in narcolepsy: rapid- eye-movement (REM) sleep without atonia and REM sleep behavior disorder. Ann. Neurol. 1992;32(1):3–10. DOI: 10.1002/ana.410320103</mixed-citation></ref><ref id="B83"><label>83.</label><mixed-citation>Dauvilliers Y., Rompre S., Gagnon J.F. et al. REM sleep characteristics in narcolepsy and REM sleep behavior disorder. Sleep. 2007;30(7):844–849. DOI: 10.1093/sleep/30.7.844</mixed-citation></ref><ref id="B84"><label>84.</label><mixed-citation>Ferri R., Franceschini C., Zucconi M. et al. Searching for a marker of REM sleep behavior disorder: submentalis muscle EMG amplitude analysis during sleep in patients with narcolepsy/cataplexy. Sleep. 2008;31(10):1409–1417.</mixed-citation></ref><ref id="B85"><label>85.</label><mixed-citation>Nightingale S., Orgill J.C., Ebrahim I.O. et al. The association between narcolepsy and REM behavior disorder (RBD). Sleep Med. 2005;6(3):253–258. DOI: 10.1016/j.sleep.2004.11.007</mixed-citation></ref><ref id="B86"><label>86.</label><mixed-citation>McCarter S.J., Tippmann-Peikert M., Sandness D.J. et al. Neuroimaging-evident lesional pathology associated with REM sleep behavior disorder. Sleep Med. 2015;16(12):1502–1510. DOI: 10.1016/j.sleep.2015.07.018</mixed-citation></ref><ref id="B87"><label>87.</label><mixed-citation>Compta Y., Iranzo A., Santamaria J. et al. REM sleep behavior disorder and narcoleptic features in antiMa2-associated encephalitis. Sleep. 2007;30(6):767–769. DOI: 10.1093/sleep/30.6.767</mixed-citation></ref><ref id="B88"><label>88.</label><mixed-citation>Cornelius J.R., Pittock S.J., McKeon A. et al. Sleep manifestations of voltage-gated potassium channel complex autoimmunity. Arch. Neurol. 2011;68(6):733–738. DOI: 10.1001/archneurol.2011.106</mixed-citation></ref><ref id="B89"><label>89.</label><mixed-citation>Iranzo A., Graus F., Clover L. et al. Rapid eye movement sleep behavior disorder and potassium channel antibody-associated limbic encephalitis. Ann. Neurol. 2006;59(1):178–181. DOI: 10.1002/ana.20693</mixed-citation></ref><ref id="B90"><label>90.</label><mixed-citation>Josephs K.A., Silber M.H., Fealey R.D. et al. Neurophysiologic studies in Morvan syndrome. J. Clin. Neurophysiol. 2004;21(6):440–445. DOI: 10.1097/00004691-200411000-00008</mixed-citation></ref><ref id="B91"><label>91.</label><mixed-citation>Tippmann-Peikert M., Boeve B.F., Keegan B.M. REM sleep beha- vior disorder initiated by acute brainstem multiple sclerosis. Neurology. 2006;66(8):1277–1279. DOI: 10.1212/01.wnl.0000208518.72660.ff</mixed-citation></ref><ref id="B92"><label>92.</label><mixed-citation>Иллариошкин С.Н., Власенко А.Г., Федотова Е.Ю. Современные возможности идентификации латентной стадии нейродегенеративного процесса. Анналы клинической и экспериментальной неврологии. 2013;7(2):39–50.</mixed-citation></ref><ref id="B93"><label>93.</label><mixed-citation>Нодель М.Р., Украинцева Ю.В., Яхно Н.Н. Синдром нарушения поведения в фазе сна с быстрыми движениями глаз при болезни Паркинсона. Неврологический журнал. 2015;20(6):28–34.</mixed-citation></ref><ref id="B94"><label>94.</label><mixed-citation>Рождественский А.С., Делов Р.А., Маркс Е.А. и др. Изучение фундаментальных и прикладных аспектов болезни Паркинсона в рамках международного консорциума GEoPD. Нервные болезни. 2020;(1):10–15. DOI: 10.24411/2226-0757-2020-12146</mixed-citation></ref></ref-list></back></article>
